Product NDC: | 0409-7248 |
Proprietary Name: | Hetastarch in Sodium Chloride |
Non Proprietary Name: | HETASTARCH |
Active Ingredient(s): | 6 g/100mL & nbsp; HETASTARCH |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-7248 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA740193 |
Marketing Category: | ANDA |
Start Marketing Date: | 20050228 |
Package NDC: | 0409-7248-03 |
Package Description: | 12 BAG in 1 CASE (0409-7248-03) > 500 mL in 1 BAG |
NDC Code | 0409-7248-03 |
Proprietary Name | Hetastarch in Sodium Chloride |
Package Description | 12 BAG in 1 CASE (0409-7248-03) > 500 mL in 1 BAG |
Product NDC | 0409-7248 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | HETASTARCH |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20050228 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc. |
Substance Name | HETASTARCH |
Strength Number | 6 |
Strength Unit | g/100mL |
Pharmaceutical Classes | Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA],Starch [Chemical/Ingredient] |